127964000: Gemtuzumab ozogamicin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Gemtuzumab ozogamicin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Gemtuzumab ozogamicin
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Gemtuzumab ozogamicin
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Gemtuzumab ozogamicin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Gemtuzumab ozogamicin

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Gemtuzumab ozogamicin

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Gemtuzumab ozogamicin
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Gemtuzumab ozogamicin
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Gemtuzumab ozogamicin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gemtuzumab ozogamicin	Is a	agent antinéoplasique	false	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	Product containing monoclonal antibody (product)	false	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	Monoclonal antibody	true	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Gemtuzumab ozogamicin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Gemtuzumab ozogamicin	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gemtuzumab ozogamicin	Inferred relationship	Some
Product containing gemtuzumab ozogamicin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing only gemtuzumab ozogamicin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Gemtuzumab ozogamicin only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gemtuzumab ozogamicin	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1251016	Gemtuzumab ozogamicin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
731907015	Gemtuzumab ozogamicin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
368931000195114	gemtuzumab ozogamicin	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
192921000077117	gemtuzumab ozogamicin	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
814361000172116	gemtuzumab ozogamicine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module